Endocrine| Volume 168, ISSUE 6, P1079-1085, December 2020

Critical analysis of the intraoperative parathyroid hormone decrease during parathyroidectomy for secondary and tertiary hyperparathyroidism

Published:August 15, 2020DOI:



      This study aims to determine whether intraoperative parathyroid hormone monitoring helps to predict early surgical outcomes in patients with renal hyperparathyroidism and evaluate the impact on decision making during surgery.


      A prospective study was conducted. Serial samples of the intraoperative parathyroid hormone were collected; 2 of these were taken before the excision, and 2 were taken after the planned parathyroid resection (10 minutes and 15 minutes). We tested the criterion of an intraoperative parathyroid hormone percentage decay ≥80% of the highest value of the basal samples as a predictor of success.


      Of the 228 patients, parathyroidectomy achieved success in 92.1%. In patients with secondary hyperparathyroidism, the failure group showed a tendency to stabilize or even increase the intraoperative parathyroid hormone values from the 10-minute measure (577 pg/mL) to the 15-minute measure (535 pg/mL) (P = .903). Conversely, intraoperative parathyroid hormone continued to drop in those with a successful outcome: 245 pg/mL (10 minutes) and 206 pg/mL (15 minutes) (P < .001). The failure group had a significantly lower percentage decay (P < .001) from baseline when compared with the success group. The intraoperative parathyroid hormone influenced the surgical management in up to 7% of the cases. The intraoperative parathyroid hormone dosage method showed an accuracy of 86%, a sensitivity of 88%, and specificity of 67%.


      In patients with renal hyperparathyroidism undergoing parathyroidectomy, the use of intraoperative parathyroid hormone may help to predict an early therapeutic outcome with high sensitivity and accuracy by indicating the operation's success when there is an 80% reduction of baseline intraoperative parathyroid hormone 15 minutes after removal of the enlarged glands, an associated continuous decrease in serum intraoperative parathyroid hormone levels between 10 and 15 minutes, and achievement of plasma target values <500 pg/mL.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Tominaga Y.
        • Tanaka Y.
        • Sato K.
        • Nagasaka T.
        • Takagi H.
        Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism.
        Semin Surg Oncol. 1997; 13: 78-86
        • Komaba H.
        • Kakuta T.
        • Fukagawa M.
        Diseases of the parathyroid gland in chronic kidney disease.
        Clin Exp Nephrol. 2011; 15: 797-809
        • Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group
        KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
        Kidney Int Suppl. 2009; 113: S1-S130
        • Pitt S.C.
        • Sippel R.S.
        • Chen H.
        Secondary and tertiary hyperparathyroidism, state of the art surgical management.
        Surg Clin North Am. 2009; 89: 1227-1239
        • National Kidney Foundation
        K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
        Am J Kidney Dis. 2003; 42: S1-S201
        • Valderrabano F.
        • Berthoux F.C.
        • Jones E.H.
        • Mehls O.
        Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA registry. European dialysis and transplant association-European renal association.
        Nephrol Dial Transplant. 1996; 11 Suppl 1: 2-21
        • Oliveira R.B.
        • Silva E.N.
        • Charpinel D.M.
        • et al.
        Secondary hyperparathyroidism status in Brazil: Brazilian census of parathyroidectomy.
        J Bras Nefrol. 2011; 33: 457-462
        • Magnabosco F.F.
        • Tavares M.R.
        • Montenegro F.L.
        Surgical treatment of secondary hyperparathyroidism: a systematic review of the literature.
        Arq Bras Endocrinol Metabol. 2014; 58: 562-571
        • Mosca L.M.
        • Filho W.A.
        • Fonseca A.K.N.
        • et al.
        Bone pain in secondary hyperparathyroidism: initial impact of the parathyroidectomy.
        Rev Bras Cir Pesc. 2013; 42: 190-193
        • Filho W.A.
        • van der Plas W.Y.
        • Brescia M.D.G.
        • et al.
        Quality of life after surgery in secondary hyperparathyroidism, comparing subtotal parathyroidectomy with total parathyroidectomy with immediate parathyroid autograft: prospective randomized trial.
        Surgery. 2018; 164: 978-985
        • Bratucu M.N.
        • Garofil N.D.
        • Radu P.A.
        • et al.
        Measurement of quality of life after total parathyroidectomy in patients with secondary hyperparathyroidism and end stage renal disease.
        Chirurgia (Bucur). 2015; 110: 511-517
        • van der Plas W.Y.
        • Dulfer R.R.
        • Engelsman A.F.
        • et al.
        • and the Dutch Hyperparathyroid Study Group (DHSG)
        Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review.
        Nephrol Dial Transplant. 2017; 32: 1902-1908
        • Goldenstein P.T.
        • Elias R.M.
        • Pires de Freitas do Carmo L.
        • et al.
        Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study.
        PLoS One. 2013; 8e68870
        • Costa-Hong V.
        • Jorgetti V.
        • Gowdak L.H.
        • Moyses R.M.
        • Krieger E.M.
        • de Lima J.J.
        Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism.
        Surgery. 2007; 142: 699-703
        • Komaba H.
        • Taniguchi M.
        • Wada A.
        • Iseki K.
        • Tsubakihara Y.
        • Fukagawa M.
        Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.
        Kidney Int. 2015; 88: 350-359
        • Freriks K.
        • Hermus A.R.
        • de Sevaux R.G.
        • et al.
        Usefulness of intraoperative parathyroid hormone measurements in patients with renal hyperparathyroidism.
        Head Neck. 2010; 32: 1328-1335
        • Numano M.
        • Tominaga Y.
        • Uchida K.
        • Orihara A.
        • Tanaka Y.
        • Takagi H.
        Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism.
        World J Surg. 1998; 22 (discussion 1103): 1098-1102
        • Vieira J.G.
        • Kunii I.S.
        • Ohe M.N.
        • Carvalho A.B.
        Heterogeneity of carboxyl-terminal parathyroid hormone circulating forms in patients with hyperparathyroidism due to end stage renal disease.
        Arq Bras Endocrinol Metabol. 2009; 53: 1074-1178
        • Carneiro D.M.
        • Solorzano C.C.
        • Nader M.C.
        • Ramirez M.
        • Irvin 3rd, G.L.
        Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?.
        Surgery. 2003; 134 (discussion 979-981): 973-979
        • Lokey J.
        • Pattou F.
        • Mondragon-Sanchez A.
        • et al.
        Intraoperative decay profile of intact (1-84) parathyroid hormone in surgery for renal hyperparathyroidism--a consecutive series of 80 patients.
        Surgery. 2000; 128: 1029-1034
        • Yamashita H.
        • Cantor T.
        • Uchino S.
        • et al.
        Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism.
        World J Surg. 2005; 29: 169-173
        • Chou F.F.
        • Lee C.H.
        • Chen J.B.
        • Hsu K.T.
        • Sheen-Chen S.M.
        Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism.
        Arch Surg. 2002; 137: 341-344
        • Irvin 3rd, G.L.
        • Dembrow V.D.
        • Prudhomme D.L.
        Operative monitoring of parathyroid gland hyperfunction.
        Am J Surg. 1991; 162: 299-302
        • Moor J.W.
        • Roberts S.
        • Atkin S.L.
        • England R.J.
        Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism.
        Head Neck. 2011; 33: 293-296
        • Seehofer D.
        • Rayes N.
        • Klupp J.
        • et al.
        Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism.
        Langenbecks Arch Surg. 2005; 390: 222-229
        • Weber T.
        • Zeier M.
        • Hinz U.
        • Schilling T.
        • Buchler M.W.
        Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism.
        World J Surg. 2005; 29: 1176-1179
        • Barczyński M.
        • Cichon S.
        • Konturek A.
        • Cichon W.
        A randomised study on a new cost-effective algorithm of quick intraoperative intact parathyroid hormone assay in secondary hyperparathyroidism.
        Langenbecks Arch Surg. 2005; 390: 121-127
        • Haustein S.V.
        • Mack E.
        • Starling J.R.
        • Chen H.
        The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation.
        Surgery. 2005; 138 (discussion 1071): 1066-1071
        • Triponez F.
        • Dosseh D.
        • Hazzan M.
        • et al.
        Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation.
        Langenbecks Arch Surg. 2006; 391: 561-565
        • Gioviale M.C.
        • Gambino G.
        • Maione C.
        • et al.
        Intraoperative parathyroid hormone monitoring during parathyroidectomy for hyperparathyroidism in waiting list and kidney transplant patients.
        Transplant Proc. 2006; 38: 1003-1005
        • Pitt S.C.
        • Panneerselvan R.
        • Chen H.
        • Sippel R.S.
        Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring.
        World J Surg. 2010; 34: 1343-1349
        • Kim W.Y.
        • Lee J.B.
        • Kim H.Y.
        Efficacy of intraoperative parathyroid hormone monitoring to predict success of parathyroidectomy for secondary hyperparathyroidism.
        J Korean Surg Soc. 2012; 83: 1-6
        • Ohe M.N.
        • Santos R.O.
        • Kunii I.S.
        • et al.
        Intraoperative PTH cutoff definition to predict successful parathyroidectomy in secondary and tertiary hyperparathyroidism.
        Braz J Otorhinolaryngol. 2013; 79: 494-499
        • Hiramitsu T.
        • Tominaga Y.
        • Okada M.
        • Yamamoto T.
        • Kobayashi T.
        A retrospective study of the impact of intraoperative intact parathyroid hormone monitoring during total parathyroidectomy for secondary hyperparathyroidism: STARD study.
        Medicine (Baltimore). 2015; 94: e1213
        • Zhang L.
        • Xing C.
        • Shen C.
        • et al.
        Diagnostic accuracy study of intraoperative and perioperative serum intact PTH level for successful parathyroidectomy in 501 secondary hyperparathyroidism patients.
        Sci Rep. 2016; 6: 26841
        • Vulpio C.
        • Bossola M.
        • Di Stasio E.
        • et al.
        Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism.
        Clin Biochem. 2016; 49: 538-543
        • Kara M.
        • Tellioglu G.
        • Bugan U.
        • et al.
        Evaluation of intraoperative parathormone measurement for predicting successful surgery in patients undergoing subtotal/total parathyroidectomy due to secondary hyperparathyroidism.
        Laryngoscope. 2010; 120: 1538-1544
        • Tominaga Y.
        Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease.
        Ups J Med Sci. 2006; 111: 277-292
        • Edwards C.M.
        • Folek J.
        • Dayawansa S.
        • et al.
        Central venous parathyroid hormone monitoring using a novel, specific anatomic method accurately predicts cure during minimally invasive parathyroidectomy.
        Am J Surg. 2016; 212: 1154-1161
        • Brossard J.H.
        • Cloutier M.
        • Roy L.
        • Lepage R.
        • Gascon-Barre M.
        • D'Amour P.
        Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.
        J Clin Endocrinol Metab. 1996; 81: 3923-3929
        • Lorenz K.
        • Dralle H.
        Will intra-operative measurement of parathyroid hormone alter the surgical concept of renal hyperparathyroidism?.
        Langenbecks Arch Surg. 2005; 390: 277-279
        • Dotzenrath C.
        • Cupisti K.
        • Goretzki E.
        • et al.
        Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients.
        Langenbecks Arch Surg. 2003; 387: 348-354
        • Gasparri G.
        • Camandona M.
        • Abbona G.C.
        • et al.
        Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies.
        Ann Surg. 2001; 233: 65-69